PLPC vs REGN · P/E 21, rev $593.7M vs P/E 14, rev $14.34B
Preformed Line Products Company (PLPC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Preformed Line Products Company (PLPC) is a electrical equipment & parts company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PLPC revenue for 2024-12-31 was $593.7M. Net income was $37.1M. Revenue was down 11.3% from 2023-12-31 to 2024-12-31. PLPC currently screens at market cap $836.3M and trailing P/E 21.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PLPC currently screens at market cap $836.3M and trailing P/E 21.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PLPC and REGN stock pages for the full models.
Not investment advice.